Affinity is a cannabis startup founded in 2017 with a mission to deliver craft-focused cannabis for the benefit of all, from newcomer to connoisseur. The company prioritizes quality as a cornerstone, emphasizing consistency through a systematic, measured, and scientific process in every aspect of the business, from strain cultivation to testing protocols. This focus ensures that Affinity products provide the same undeniable results every time, catering to the discerning expectations of cannabis consumers. In addition to its commitment to product quality, Affinity is dedicated to being best-in-class in all aspects. The company prides itself on selective hiring, resulting in a smart, collaborative, and enthusiastic team. It prioritizes employee well-being, aligning skills and interests with company needs and providing strong support. Affinity offers a competitive benefits package, with the company contributing significantly to medical insurance premiums and covering all dental and vision programs. Currently based in the United States, Affinity represents an intriguing player in the retail cannabis sector. Notably, the company has not disclosed its latest investment details, potentially indicating that it is either in the early stages of seeking funding or maintaining a more discreet approach to investor relations. This deliberate approach could speak to a strategic and cautious operating style, potentially appealing to investors seeking a balanced approach to growth and development in the rapidly evolving cannabis industry.
There is no investment information
No recent news or press coverage available for Affinity.